FDA Clearance Tracker · DEN190034
Control-IQ Technology
Last checked: Nov 19, 2026Latest source record: Dec 13, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2019
De Novo granted
Time to decision
151 days
Received Jul 15, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN190034
- Device name
- Control-IQ Technology
- Applicant
- Tandem Diabetes Care, Inc.
- Applicant location
- San Diego, CA
- Received
- Jul 15, 2019
- Decided
- Dec 13, 2019
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1356
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN190034
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Tandem Diabetes Care, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Control-IQ+ technology510(k)
K260429 · Decided Apr 24, 2026 · 73 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K253074 · Decided Nov 6, 2025 · 44 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K250792 · Decided Sep 24, 2025 · 194 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.